![Cytarabine (cytosine Arabinoside, Ara-c) Chemotherapy Drug Molecule. Used In Treatment Of Acute Myeloid Leukemia (aml), Acute Lymphocytic Leukemia (all) And Lymphoma. Skeletal Formula. Stock Photo, Picture And Royalty Free Image. Image 93261187. Cytarabine (cytosine Arabinoside, Ara-c) Chemotherapy Drug Molecule. Used In Treatment Of Acute Myeloid Leukemia (aml), Acute Lymphocytic Leukemia (all) And Lymphoma. Skeletal Formula. Stock Photo, Picture And Royalty Free Image. Image 93261187.](https://previews.123rf.com/images/molekuul/molekuul1801/molekuul180100147/93261187-cytarabine-cytosine-arabinoside-ara-c-chemotherapy-drug-molecule-used-in-treatment-of-acute-myeloid-.jpg?fj=1)
Cytarabine (cytosine Arabinoside, Ara-c) Chemotherapy Drug Molecule. Used In Treatment Of Acute Myeloid Leukemia (aml), Acute Lymphocytic Leukemia (all) And Lymphoma. Skeletal Formula. Stock Photo, Picture And Royalty Free Image. Image 93261187.
![Neurotoxicity of cytarabine (Ara-C) in dorsal root ganglion neurons originates from impediment of mtDNA synthesis and compromise of mitochondrial function - ScienceDirect Neurotoxicity of cytarabine (Ara-C) in dorsal root ganglion neurons originates from impediment of mtDNA synthesis and compromise of mitochondrial function - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0891584918307457-fx1.jpg)
Neurotoxicity of cytarabine (Ara-C) in dorsal root ganglion neurons originates from impediment of mtDNA synthesis and compromise of mitochondrial function - ScienceDirect
![RNA expression of genes involved in cytarabine metabolism and transport predicts cytarabine response in acute myeloid leukemia | Pharmacogenomics RNA expression of genes involved in cytarabine metabolism and transport predicts cytarabine response in acute myeloid leukemia | Pharmacogenomics](https://www.futuremedicine.com/cms/10.2217/pgs.15.44/asset/images/medium/figure1.gif)
RNA expression of genes involved in cytarabine metabolism and transport predicts cytarabine response in acute myeloid leukemia | Pharmacogenomics
![Ribonucleotide reductase inhibitors suppress SAMHD1 ara‐CTPase activity enhancing cytarabine efficacy | EMBO Molecular Medicine Ribonucleotide reductase inhibitors suppress SAMHD1 ara‐CTPase activity enhancing cytarabine efficacy | EMBO Molecular Medicine](https://www.embopress.org/cms/asset/89c1ed6c-1071-4e12-bc01-c5c9e4936c79/emmm201910419-fig-0001ev-m.jpg)
Ribonucleotide reductase inhibitors suppress SAMHD1 ara‐CTPase activity enhancing cytarabine efficacy | EMBO Molecular Medicine
![X‐linked inhibitor of apoptosis inhibition sensitizes acute myeloid leukemia cell response to TRAIL and chemotherapy through potentiated induction of proapoptotic machinery - Zhou - 2018 - Molecular Oncology - Wiley Online Library X‐linked inhibitor of apoptosis inhibition sensitizes acute myeloid leukemia cell response to TRAIL and chemotherapy through potentiated induction of proapoptotic machinery - Zhou - 2018 - Molecular Oncology - Wiley Online Library](https://febs.onlinelibrary.wiley.com/cms/asset/7a662cd6-4e37-40f6-9050-db057fcc2738/mol212146-fig-0006-m.jpg)
X‐linked inhibitor of apoptosis inhibition sensitizes acute myeloid leukemia cell response to TRAIL and chemotherapy through potentiated induction of proapoptotic machinery - Zhou - 2018 - Molecular Oncology - Wiley Online Library
![Structural insights into mutagenicity of anticancer nucleoside analog cytarabine during replication by DNA polymerase η | Scientific Reports Structural insights into mutagenicity of anticancer nucleoside analog cytarabine during replication by DNA polymerase η | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-019-52703-7/MediaObjects/41598_2019_52703_Fig5_HTML.png)
Structural insights into mutagenicity of anticancer nucleoside analog cytarabine during replication by DNA polymerase η | Scientific Reports
The high NRF2 expression confers chemotherapy resistance partly through up-regulated DUSP1 in myelodysplastic syndromes | Haematologica
Sgc8 aptamer targeted glutathione-responsive nanoassemblies containing Ara-C prodrug for the treatment of acute lymphoblastic leukemia - Nanoscale (RSC Publishing)
![AraC-like transcriptional activator CuxR binds c-di-GMP by a PilZ-like mechanism to regulate extracellular polysaccharide production | PNAS AraC-like transcriptional activator CuxR binds c-di-GMP by a PilZ-like mechanism to regulate extracellular polysaccharide production | PNAS](https://www.pnas.org/cms/10.1073/pnas.1702435114/asset/8a14861f-aaf7-47f1-891f-34f75ef6c4d1/assets/graphic/pnas.1702435114sfig02.jpeg)